Characterization of a putative ovarian oncogene, elongation factor 1α isolated by panninga synthetic phage display single-chain variable fragment library with cultured human ovarian cancer cells

Clinical Cancer Research

Volumn 13, Issue 19, 2007, Pages 5889-5896

  Sharma, Sameer ^a   Tammela, Jonathan ^a   Wang, Xinhui ^a   Arnouk, Hilal ^a   Driscoll, Deborah ^a   Mhawech Fauceglia, Paulette ^a   Lele, Shashikant ^a   Latif Kazim, A ^a   Odunsi, Kunle ^a  

^a ROSWELL PARK CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DNA; ELONGATION FACTOR; ELONGATION FACTOR 1ALPHA; MESSENGER RNA; MULTILOAD COPPER INTRAUTERINE DEVICE; PEROXIDASE; PROTEIN EEF1A1; PROTEIN EEF1A2; SINGLE CHAIN FRAGMENT VARIABLE ANTIBODY; UNCLASSIFIED DRUG;

ADULT; AGED; AMINO ACID SEQUENCE; ANTIBODY ISOLATION; ARTICLE; BRAIN TISSUE; CANCER CELL CULTURE; CANCER RECURRENCE; CELL LYSATE; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HEART; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOPRECIPITATION; ONCOGENE; OVARY CANCER; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SKELETAL MUSCLE; TANDEM MASS SPECTROMETRY;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA; CELL LINE, TUMOR; FEMALE; HUMANS; IMMUNOGLOBULIN VARIABLE REGION; MIDDLE AGED; OVARIAN NEOPLASMS; OVARY; PEPTIDE ELONGATION FACTOR 1; PEPTIDE LIBRARY; PROTEIN BIOSYNTHESIS; TISSUE DISTRIBUTION;

EID: 35348882142     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: 10.1158/1078-0432.CCR-07-0703     Document Type: Article

References (42)

1. Greenlee RT, Hill-Harmon MB, Murray T, Thun M. Cancer statistics, 2001. CA Cancer J Clin 2001;51:15-36.
2. McGuire WP, Hoskins WJ, Brady MF, et al. Cyclophosphamide and cisplatin versus paclitaxel and cisplatin: a phase III randomized trial in patients with suboptimal stage III/IV ovarian cancer (from the Gynecologic Oncology Group). Semin Oncol 1996;23:40-7.
3. Ghadersohi A, Chitta K, Greco WR, et al. Tumor antigens and markers for breast and ovarian cancers. Front Biosci 2002;7:e48-57.
4. McCafferty J, Griffiths AD, Winter G, Chiswell DJ. Phage antibodies: filamentous phage displaying antibody variable domains. Nature 1990;348:552-4.
5. Griffiths AD, Williams SC, Hartley O, et al. Isolation of high affinity human antibodies directly from large synthetic repertoires. EMBO J 1994;13:3245-60.
6. Vaughan TJ, Williams AJ, Pritchard K, et al. Human antibodies with sub-nanomolar affinities isolated from a large non-immunized phage display library. Nat Biotechnol 1996;14:309-14.
7. Sheets MD, Amersdorfer P, Finnern R, et al. Efficient construction of a large nonimmune phage antibody library: the production of high-affinity human single-chain antibodies to protein antigens. Proc Natl Acad Sci U S A 1998;95:6157-62.
8. Nissim A, Hoogenboom HR, Tomlinson IM, et al. Antibody fragments from a 'single pot' phage display library as immunochemical reagents. EMBO J 1994;13:692-8.
9. Ridgway JB, Ng E, Kern JA, et al. Identification of a human anti-CD55 single-chain Fv by subtractive panning of a phage library using tumor and nontumor cell lines. Cancer Res 1999;59:2718-23.
10. Marks JD, Ouwehand WH, Bye JM, et al. Human antibody fragments specific for human blood group antigens from a phage display library. Biotechnology (NY) 1993;11:1145-9.
11. Portolano S, McLachlan SM, Rapoport B. High affinity, thyroid-specific human autoantibodies displayed on the surface of filamentous phage use V genes similar to other autoantibodies. J Immunol 1993;151:2839-51.
12. de Kruif J, Terstappen L, Boel E, Logtenberg T. Rapid selection of cell subpopulation-specific human monoclonal antibodies from a synthetic phage antibody library. Proc Natl Acad Sci U S A 1995;92:3938-42.
13. Van Ewijk W, de Kruif J, Germeraad WT, et al. Subtractive isolation of phage-displayed single-chain antibodies to thymic stromal cells by using intact thymic fragments. Proc Natl Acad Sci U S A 1997;94:3903-8.
14. Cai X, Garen A. Anti-melanoma antibodies from melanoma patients immunized with genetically modified autologous tumor cells: selection of specific antibodies from single-chain Fv fusion phage libraries. Proc Natl Acad Sci U S A 1995;92:6537-41.
15. Cai X, Garen A. A melanoma-specific VH antibody cloned from a fusion phage library of a vaccinated melanoma patient. Proc Natl Acad Sci U S A 1996;93:6280-5.
16. Cai X, Garen A. Comparison of fusion phage libraries displaying VH or single-chain Fv antibody fragments derived from the antibody repertoire of a vaccinated melanoma patient as a source of melanoma-specific targeting molecules. Proc Natl Acad Sci U S A 1997;94:9261-6.
17. Noronha EJ, Wang X, Desai SA, Kageshita T, Ferrone S. Limited diversity of human scFv fragments isolated by panning a synthetic phage-display scFv library with cultured human melanoma cells. J Immunol 1998;161:2968-76.
18. Lee S, Francoeur AM, Liu S, Wang E. Tissue-specific expression in mammalian brain, heart, and muscle of S1, a member of the elongation factor-1α gene family. J Biol Chem 1992;267:24064-8.
19. Anand N, Murthy S, Amann G, et al. Protein elongation factor EEF1A2 is a putative oncogene in ovarian cancer. Nat Genet 2002;31:301-5.
20. Desai SA, Wang X, Noronha EJ, Kageshita T, Ferrone S. Characterization of human anti-high molecular weight-melanoma-associated antigen single-chain Fv fragments isolated from a phage display antibody library. Cancer Res 1998;58:2417-25.
21. Miller JH. Experiments in molecular genetics. Cold Spring Harbor (NY): Cold Spring Harbor Laboratory Press; 1972.
22. Marks JD, Hoogenboom HR, Bonnert TP, McCafferty J, Griffiths AD, Winter G. By-passing immunization. Human antibodies from V-gene libraries displayed on phage. J Mol Biol 1991;222:581-97.
23. Schier R, Bye J, Apell G, et al. Isolation of high-affinity monomeric human anti-c-erbB-2 single chain Fv using affinity-driven selection. J Mol Biol 1996;255:28-43.
24. Skerra A, Pluckthun A. Assembly of a functional immunoglobulin Fv fragment in Escherichia coli. Science 1988;240:1038-41.
25. Wang X, Campoli M, Ko E, Luo W, Ferrone S. Enhancement of scFv fragment reactivity with target antigens in binding assays following mixing with anti-tag monoclonal antibodies. J Immunol Methods 2004;294:23-35.
26. Evan GI, Lewis GK, Ramsay G, Bishop JM. Isolation of monoclonal antibodies specific for human c-myc proto-oncogene product. Mol Cell Biol 1985;5:3610-6.
27. Wang X, Desai S, Noronha EJ, Mittelman A, Ferrone S. The anti-idiotypic approach to active specific immunotherapy of malignant melanoma. In: Shoenfeld Y, Ferrone S, Kennedy R, editors. Idiotypes in medicine: infections, autoimmunity and cancer. The Netherlands: Elsevier Publishers B.V.; 1997. p. 523-36.
28. Serov SF, Scully RE, Sobin LH. Histological typing of ovarian tumours. International Histological Classification of Tumours, No. 9. Geneva: World Health Organization; 1973.
29. SPSS. SPSS advanced statistics. 7.5 ed. Chicago: SPSS; 1997.
30. Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc 1958;53:457-86.
31. Cox DR. Regression models and life-tables. J R Stat Soc B 1972;34:187-220.
32. D'Urso CM, Wang ZG, Cao Y, Tatake R, Zeff RA, Ferrone S. Lack of HLA class I antigen expression by cultured melanoma cells FO-1 due to a defect in B2m gene expression. J Clin Invest 1991;87:284-92.
33. +/regulatory T cell ratio are associated with favorable prognosis in ovarian cancer. Proc Natl Acad Sci U S A 2005;102:18538-43.
34. Liang P, Pardee AB. Differential display of eukaryotic messenger RNA by means of the polymerase chain reaction. Science 1995;267:1186-7.
35. Ann DK, Moutsatsos IK, Nakamura T, et al. Isolation and characterization of the rat chromosomal gene for a polypeptide (pS1) antigenically related to statin. J Biol Chem 1991;266:10429-37.
36. Knudsen SM, Frydenberg J, Clark BF, Leffers H. Tissue-dependent variation in the expression of elongation factor-1α isoforms: isolation and characterisation of a cDNA encoding a novel variant of human elongation- factor 1α. Eur J Biochem 1993;215:549-54.
37. Lund A, Knudsen SM, Vissing H, Clark B, Tommerup N. Assignment of human elongation factor 1α genes: EEF1A maps to chromosome 6q14 and EEF1A2 to 20q13.3. Genomics 1996;36:359-61.
38. Tanner MM, Grenman S, Koul A, et al. Frequent amplification of chromosomal region 20q12-q13 in ovarian cancer. Clin Cancer Res 2000;6:1833-9.
39. Diebold J, Mosinger K, Peiro G, et al. 20q13 and cyclin D1 in ovarian carcinomas. Analysis by fluorescence in situ hybridization. J Pathol 2000;190:564-71.
40. Potter M, Bernstein A, Lee JM. The wst gene regulates multiple forms of thymocyte apoptosis. Cell Immunol 1998;188:111-7.
41. Joseph P, O'Kernick CM, Othumpangat S. Translation elongation factor 1A2 (TEF1A2) is a tumor marker and an inhibitor of cadmium-induced apoptosis. Proc Amer Assoc Cancer Res 2004;45:209.
42. Johnsson A, Zeelenberg I, Min Y, et al. Identification of genes differentially expressed in association with acquired cisplatin resistance. Br J Cancer 2000;83:1047-54.